SLI
2.011,17
PKT
+2,76
PKT
+0,14
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
14.03.19 | Roche buy | Jefferies & Company Inc. | |
14.03.19 | Zurich Insurance Hold | Jefferies & Company Inc. | |
14.03.19 | Zurich Insurance Hold | Jefferies & Company Inc. | |
14.03.19 | Swiss Re Sell | UBS AG | |
13.03.19 | Holcim Sell | UBS AG | |
13.03.19 | UBS Neutral | JP Morgan Chase & Co. | |
12.03.19 | Holcim Outperform | Credit Suisse Group | |
12.03.19 | Holcim overweight | JP Morgan Chase & Co. | |
11.03.19 | Givaudan Underperform | Credit Suisse Group | |
08.03.19 | UBS Sector Perform | RBC Capital Markets | |
08.03.19 | UBS Sector Perform | RBC Capital Markets | |
07.03.19 | UBS buy | HSBC | |
07.03.19 | Holcim Underweight | Barclays Capital | |
07.03.19 | Holcim Sell | UBS AG | |
07.03.19 | Holcim Neutral | Goldman Sachs Group Inc. | |
07.03.19 | UBS overweight | JP Morgan Chase & Co. | |
06.03.19 | Swiss Re Hold | Jefferies & Company Inc. | |
04.03.19 | Holcim Outperform | Credit Suisse Group | |
04.03.19 | Swiss Re Sector Perform | RBC Capital Markets | |
04.03.19 | Novartis Neutral | UBS AG | |
04.03.19 | Roche Neutral | UBS AG | |
04.03.19 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
04.03.19 | Holcim overweight | JP Morgan Chase & Co. | |
01.03.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
28.02.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
28.02.19 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
28.02.19 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
28.02.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
27.02.19 | Swiss Re buy | Goldman Sachs Group Inc. | |
26.02.19 | Roche Hold | Deutsche Bank AG | |
26.02.19 | Novartis Underweight | JP Morgan Chase & Co. | |
26.02.19 | Holcim Outperform | Credit Suisse Group | |
26.02.19 | Nestlé buy | Jefferies & Company Inc. | |
26.02.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
25.02.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
25.02.19 | Roche Neutral | Credit Suisse Group | |
25.02.19 | Roche overweight | Barclays Capital | |
25.02.19 | Roche overweight | JP Morgan Chase & Co. | |
25.02.19 | Roche buy | Goldman Sachs Group Inc. | |
25.02.19 | Nestlé market-perform | Bernstein Research |